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Abstract
Background: Recently, several genome-wide and candidate gene association studies have identified many novel 
genetic loci for type 2 diabetes (T2D); among these genes, CDKAL1, IGF2BP2, SLC30A8, CDKN2A/B, HHEX, FTO, TCF2, 
KCNQ1, and WFS1 are the most important. We aimed to determine the effects of these genetic loci associated with T2D 
in the Chinese Han population of China.
Methods: Single-nucleotide polymorphisms (SNPs) in or near CDKAL1, IGF2BP2, SLC30A8, CDKN2A/B, HHEX, FTO, TCF2, 
KCNQ1, and WFS1 genes were genotyped in a case-control Chinese Han sample living in Beijing, China involving 1024 
patients with T2D and 1005 control subjects.
Results: In Chinese Han, we replicated the associations between 7 genetic loci and T2D, with risk allele-specific odds 
ratios (ORs) as follows: 1.27 (95% CI, 1.11-1.45; p = 0.0008) for CDKAL1-rs10946398, 1.26 (95% CI, 1.08-1.47; p = 0.003) for 
IGF2BP2-rs4402960, 1.19 (95% CI, 1.04-1.37; p = 0.009) for SLC30A8-rs13266634, 1.22 (95% CI, 1.06-1.41; p = 0.005) for 
CDKN2A/B-rs10811661, 1.20 (95% CI, 1.01-1.42; p = 0.03) for HHEX-rs5015480, 1.37 (95% CI, 1.19-1.69; p = 1.0 × 10-4) for 
KCNQ1-rs2237892, and 1.24 (95% CI, 1.01-1.52; p = 0.046) for FTO-rs8050136 after adjustment for age, gender, and body 
mass index. Not only did an association between WFS1-rs6446482 and early-onset T2D exist in the subgroup analysis, 
but TCF2-rs7501939 and WFS1-rs6446482 were also confirmed to confer risk for T2D in this meta-analysis. Moreover, the 
relationship between FTO-rs8050136 and body mass index, together with the effect of CDKAL1-rs10946398 on beta cell 
function, was also observed in the control individuals.
Conclusions: Our findings support the important contribution of these genetic loci to susceptibility for T2D in the 
Chinese Han population in Beijing of China.
Background
Genome-wide association studies (GWAS) have identi-
fied many novel susceptibility genes for type 2 diabetes
(T2D) since 2007. In the early GWAS, common variants
in  IGF2BP2,  CDKAL1,  SLC30A8,  HHEX,  CDKN2A/B,
FTO, and TCF2 loci were reported to increase the risk of
T2D in Caucasians [1-6], and KCNQ1 was recently dis-
covered as a new diabetogenic gene in Japanese samples
[7]. In addition, the Wolfram syndrome 1(WFS1) gene is
one of the novel susceptibility genes for T2D identified by
the candidate gene approach in Caucasians until recently
[8]. Compared with the susceptibility genes for T2D
revealed in the following meta-analysis of GWAS [9],
these 9 genes, which were discovered in relatively smaller
samples, might represent the most diabetogenic genes
and have larger effect sizes in the studied populations.
Although these associations have been replicated in Cau-
casians, the roles of some loci remain less clear in Chi-
nese. For example, in the Chinese Han population, the
associations between single nucleotide polymorphisms
(SNPs) at the HHEX, IGF2BP2, TCF2, and FTO loci with
T2D were not consistently replicated [6,10-15], and the
findings in previous studies involving Caucasians for
SNPs at the WFS1 locus have not been confirmed [12].
Moreover, in contrast to the large-scale association stud-
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ies in a European Caucasian population, such studies in
China often have a relatively small sample size, and meta-
analysis is becoming particularly useful to evaluate the
effects of these genes.
Therefore, we hypothesized that the aforementioned
genes were also the most important susceptibility genes
for T2D in the Chinese Han population living in China.
We aimed to test this hypothesis in a case-control study
and perform a meta-analysis of all published data for
these genetic loci in the Chinese Han population to fully
evaluate their effects.
Methods
Subjects
A total of 2029 individuals, including 1024 patients with
T2D and 1005 control subjects, were included in the
present study. All participants were unrelated and of
Northern Han Chinese ancestry residing in the Beijing
metropolitan area. The patients were recruited from the
Endocrinology and Metabolism Outpatient Clinics of
Peking University People's Hospital in Beijing, China, and
were diagnosed with T2D in accordance with the 1999
WHO criteria (fasting plasma glucose ≥7.0 mmol/l and/
or 2-h plasma glucose ≥11.1 mmol/l) [16]. Patients diag-
nosed with T2D before 30 years of age, those with an ele-
vated body mass index (BMI; > 35 kg/m2), or those with
other clinical and genetic features for specific-type diabe-
tes (e.g., maturity onset diabetes of the young [MODY])
were excluded from the study [17,18]. The control sub-
jects were selected from communities near Peking Uni-
versity People's Hospital. The inclusion criteria for the
control subjects in this study were as follows: (1) normal
glucose regulation confirmed by a 75 g oral glucose toler-
ance test (OGTT) according to the 1999 WHO criteria
(fasting plasma glucose <6.1 mmol/l and 2-h plasma glu-
cose <7.8 mmol/l), (2) no family history of T2D, (3) >40
years of age, and (4) a BMI ≤ 35 kg/m2. The clinical fea-
tures of the participants are summarized in Table 1.
Informed consent was obtained from every participant,
and the study protocol was approved by the Ethics Com-
mittee of Peking University People's Hospital.
Anthropometric and biological measurements
All of the patients with T2D and control subjects were
examined in the morning after an overnight fast for at
least 8 hours, with measurements of height, weight, and
blood pressure. Blood samples were collected for bio-
chemical measurements of fasting plasma glucose for all
the participants, and 2-hour plasma glucose during a 75 g
OGTT for the controls. The plasma glucose concentra-
tions were measured by the glucose oxidase-peroxidase
method. The fasting serum insulin concentrations were
measured by an electrochemiluminescence immunoassay
on a Roche Elecsys 2010 Chemistry Analyzer. The
homeostasis model assessment of the insulin resistance
index (HOMA-IR) and beta-cell function (HOMA-ί)
were assessed, as described previously [19].
Genotyping
Nine SNPs representing nine genes identified in recent
GWAS or large candidate gene studies [1-8] were
selected, including SLC30A8-rs13266634,  HHEX-
rs5015480,  CDKAL1-rs10946398,  CDKN2A/B-
rs10811661, IGF2BP2-rs4402960, FTO-rs8050136, TCF2-
rs7501939,  KCNQ1-rs2237892, and WFS1-  rs6446482.
Genotyping of these SNPs was performed with an ABI
SNaPshot® Multiplex System (Applied Biosystems, Foster
City, CA, USA) in the Chinese National Human Genome
Center in Shanghai. Genotyping accuracy, as determined
from the genotype concordance between duplicate sam-
ples (130 samples), was 100%. The genotyping success
rate was >95% for the patient and control groups.
Statistical analysis
Data are given as the means ± SD for quantitative vari-
ables with a normal distribution, and as medians (inter-
quartile range) for non-normally distributed data. Fasting
serum insulin, HOMA-IR, and HOMA-ί were natural
logarithm-transformed to normal distributions before
statistical analysis.
Characteristics were compared and tested for signifi-
cant differences between patients and controls using Stu-
dent's t test for continuous variables, and using χ2 test for
categorical variable. Chi-squared tests were used to
determine whether or not individual polymorphisms
were in Hardy-Weinberg equilibrium (p > 0.05). The dif-
ferences in allele and genotype frequencies between the
patients with T2D and controls were analyzed using Pear-
son's χ2 test. Logistic regression analysis was performed
to calculate risk allele-specific odds ratios (ORs), 95%
confidential intervals (CIs), and corresponding p -values
after adjustment for gender, age, and BMI as covariates;
under an additive model, 10,000 permutations were used
to obtain a true estimate for statistical significance.
Linear regression was applied to test quantitative vari-
ables for differences between the genotype groups. SNPs
that showed nominal evidence for an association between
the age of diagnosis (AOD) for T2D, fasting plasma glu-
cose, fasting serum insulin, HOMA-ί, and HOMA-IR
were adjusted by age, gender and BMI. Additionally, BMI
was adjusted for age and gender. All analyses were
adjusted using linear regression on a priori genotypic
models (dominant, additive. and recessive). Due to a lack
of validity of the large sample χ2 test statistic, only the
dominant model was considered for SNPs with ≤10 indi-Han et al. BMC Medical Genetics 2010, 11:81
http://www.biomedcentral.com/1471-2350/11/81
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viduals homozygous for the minor allele (for WFS1 and
FTO loci in the present study).
All statistical tests were performed by PLINK, version
1.06 http://pngu.mgh.harvard.edu/~purcell/plink or
SPSS, version 11.5 for Windows (SPSS, Inc., Chicago, IL,
USA). A p-value < 0.05 was considered statistically signif-
icant (two-tailed).
Power calculations were performed using Quanto soft-
ware (available at http://hydra.usc.edu/gxe/), and the
powers shown in Additional file 1, Table S1 were calcu-
lated using ORs from published studies, sample sizes and
minor allele frequencies (MAF) in the present study, the
prevalence of T2D in Chinese of mainland China [20],
and the type 1 error rate (0.05).
Pairwise linkage disequilibrium (LD) coefficients (r2)
between SNPs were calculated by Haploview software,
version 4.0 (Daly Lab at the Broad Institute, Cambridge,
MA, USA).
To identify studies eligible for meta-analysis, MED-
LINE citations (January 2000-January 2010) were sur-
veyed using the National Library of Medicine's PubMed
on-line search engine with each susceptibility gene name
(CDKAL1, IGF2BP2, SLC30A8, CDKN2A/B, HHEX,
KCNQ1, FTO, TCF2, and WFS1) and Chinese as key
words. The retrieved references were read to identify
studies that examined the allelic associations between the
SNPs within the above nine genetic regions and T2D in
Chinese Han living in China. For meta-analysis of WFS1,
FTO, and TCF2, the C allele of WFS1-rs6446482, the A
allele of FTO-rs8050136, and the T allele of TCF2-
rs7501939 were used as surrogates for the minor A allele
of WFS1- rs10010131, the A allele of FTO-rs9939609, and
the G allele of TCF2-rs4430796 because they are in strong
LD (r2 = 1) in a HapMap Chinese Han population. In the
meta-analysis, Cochran's x2-based Q-statistic test was
performed to assess heterogeneity in all of the studies
included, and a random-effect model was adopted when
heterogeneity existed, otherwise a fixed-effects model
was appropriate. Combined ORs were calculated using
the Mantel-Haenszel (fixed-effects) and DerSimonian
and Laird (random-effects) tests. The significant P value
of overall ORs was determined using the Z-test. All cal-
culations for the meta-analysis were performed on
Revman42 (provided by Cochrane-Collaboration, avail-
able at http://ims.cochrane.org/revman/download/rev-
man-4).
Results
Association study
We have successfully genotyped all nine SNPs. There
were no significant departures from the Hardy-Weinberg
equilibrium for all SNPs in the control group (p > 0.05) as
assessed by a χ2 test. In Table 2, we present for each SNP
the genotype and allele distributions, risk allele-specific
ORs, and p-values under an additive genetic model after
correction for gender, age, and BMI. The allele frequen-
cies of all SNPs in our studied population (Additional file
1, Table S1) are comparable to those of the Chinese Han
population and different from Europeans in HapMap
(http://www.hapmap.org/, accessed Feb 2009). The asso-
c i a t i o n s  o f  7  S N P s  w i t h  T 2 D  w e r e  o b s e r v e d ,  w h i c h
included, as follows: CDKAL1-rs10946398 (OR, 1.27; 95%
CI, 1.11-1.45; empirical p = 0.0008); IGF2BP2-rs4402960
(OR, 1.26; 95% CI, 1.08-1.47; empirical p = 0.003);
SLC30A8-rs13266634(OR, 1.19; 95% CI,1.04-1.37; empir-
ical p = 0.009); CDKN2A/B-rs10811661(OR, 1.22; 95%
CI, 1.06-1.41; empirical p = 0.005); HHEX-rs5015480
(OR,1.20; 95% CI, 1.01-1.42; empirical p = 0.03); and
KCNQ1-2237892 (OR, 1.37; 95% CI, 1.19-1.69; empirical
p = 1.0 × 10-4). Interestingly, FTO-rs8050136 was also
Table 1: Clinical characteristics of the participants.
Characteristics Controls Patients P
Male/Female 343/662 540/484 <0.00001
Age at examination(years) 58 ± 9 56 ± 12 <0.00001
BMI(kg/m2) 25.0 ± 3.3 25.0 ± 3.1 0.87
Age of diagnosis(years) -- 49 ± 11 --
Fasting glucose (mmol/l) 5.2 ± 0.4 7.8 ± 2.8 <0.00001
Glucose at 2 h (mmol/l) 5.7 ± 1.2 -- --
Fasting insulin (pmol/l) 53.1(38.0-77.5) -- --
HOMA-IR 1.60(1.13-2.36) -- --
HOMA-ß 80.51(57.63-111.72) -- --
Data are the mean ± SD or median(interquartile range). p represents the significance of the differences between the patients and controls.
The gender distribution between the patients and controls was analyzed using Pearson's χ2 test.
Comparison of the quantitative variables between patients and controls was performed using Student's t-test.H
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Table 2: Association with type 2 diabetes in the Chinese Han population.
Chr SNPs Genes Genotypes distribution a Genotypic 
Pnominal
Minor/Major 
Alleles
RAF Odd ratio 
(95%CI)
Allelic Pnominal
c Allelic 
Ppermuted
d
Patients bb/Bb/BB Controls Bb/Bb/BB Patients Controls
9 rs10811661 CDKN2A/B 145:514:343 191:514:279 0.002 C/T 0.60 0.55 1.22(1.06-1.41) 0.005 0.005
8 rs13266634 SLC30A8 149:457:386 179:487:327 0.01 T/C 0.62 0.57 1.19(1.04-1.37) 0.009 0.009
4 rs6446482 WFS1 0:71:914 2:91:880 0.06 C/G 0.96 0.95 1.39(0.98-1.92) 0.06 0.06
10 rs5015480 HHEX 43:336:627 31:290:668 0.04 C/T 0.21 0.18 1.20(1.01-1.42) 0.03 0.03
17 rs7501939 TCF2 89:443:460 73:378:490 0.04 T/C 0.31 0.28 1.12(0.97-1.30) 0.12 0.12
6 rs10946398 CDKAL1 240:472:286 170:498:323 0.0006 C/A 0.48 0.42 1.27(1.11-1.45) 0.0006 0.0008
16 rs8050136 FTO 17:229:761 10:195:790 0.08 A/C 0.13 0.11 1.24(1.01-1.52) 0.041 0.046
3 rs4402960 IGF2BP2 76:418:503 53:356:571 0.001 T/G 0.29 0.24 1.26(1.08-1.47) 0.003 0.003
11 rs2237892 KCNQ1 69:396:525 107:437:415 1.23 × 10-5 T/C 0.73 0.66 1.37(1.19-1.69) 2.47 × 10-5 1.0 × 10-4
a. Genotype distributions are shown as the counts of three genotypes (bb, Bb, and BB). b, Minor allele; B, Major allele. RAF, Risk allele; OR, Risk allele-specific odds ratios calculated by logistic 
regression analysis. c. Adjusted for age, gender, and BMI. d. Permutation for 10,000 times. Bold indicates the risk allele.Han et al. BMC Medical Genetics 2010, 11:81
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associated with T2D (OR, 1.25; 95% CI, 1.02-1.52; empir-
ical p = 0.029), which remained significant after adjust-
ment for age, gender, and BMI (OR,1.24; 95% CI, 1.01-
1.52; empirical p = 0.046). However, no association with
diabetes was found for TCF2-rs7501939 and WFS1  -
rs6446482.
Meta-analysis
All published studies and references are shown in Addi-
tional file 1, Table S2, which indicates the inconsistency
for associations between HHEX, IGF2BP2, TCF2, and
FTO with T2D, the low MAF of WFS1-rs6446482 and
FTO-rs8050136, and the small sample sizes in all studies
in Chinese compared with those in Caucasian popula-
tions. Except for the Li study [13] due to the lack of allelic
frequencies, the data from other studies and the current
study were included in this meta-analysis to improve the
power in evaluating the collective evidence on the rela-
tionships of these nine genetic loci to T2D, especially
HHEX, IGF2BP2, TCF2 FTO, and WFS1  genetic loci.
Table 3 shows the outcome of the meta-analysis. Overall,
the pooled ORs for T2D were significant for HHEX-
rs5015480 (pooled OR,1.24; p  < 0.00001), IGF2BP2-
rs4402960 (pooled OR, 1.14; p  = 0.0002), TCF2-
rs7501939 (pooled OR, 1.16; p  < 0.00001), FTO-
rs8050136 (pooled OR, 1.17; p  < 0.00001), WFS1-
rs6446482 (pooled OR, 1.26; p  = 0.009), CDKAL1-
rs10946398 (pooled OR, 1.24; p  < 0.00001), SLC30A8-
rs13266634 (pooled OR, 1.19; p < 0.00001), CDKN2A/B-
rs10811661 (pooled OR, 1.28; p < 0.00001), and KCNQ1-
2237892 (pooled OR, 1.33; p < 0.00001).
Genotype-phenotype relationship analysis
Genotype-age of diagnosis (AOD) for diabetes For the
patients with T2D, multiple linear regression was used to
evaluate the effect of nine representative SNPs on AOD
with adjustment for gender and BMI under a priori mod-
els. The analysis revealed that only WFS1-rs6446482 was
negatively related to AOD under a dominant model (p =
0.02), and the patients with one or two risk alleles of
WFS1- rs6446482 were diagnosed approximately 3 years
earlier than those without risk alleles (49 ± 11 years ver-
sus 52 ± 11 years, p = 0.03). Prompted by this observa-
tion, we performed a subgroup analysis of 406 early-onset
T2D patients (age of diagnosis %45 years) and 973 con-
trol subjects, showing that WFS1- rs6446482 was signifi-
cantly associated with early-onset T2D (risk allele-
specific OR, 1.96; 95% CI, 1.05-4.76; nominal p = 0.03;
empiric p = 0.03) after adjustment for gender, age, and
BMI.
Genotype-BMI For analysis of the genotype-BMI rela-
tionship, only the control subjects were examined
because the treatment for T2D might distort the relation-
ship. Only FTO-rs8050136 of nine genetic loci was found
to be significantly associated with BMI (p = 0.04) after
adjusting for gender and age as covariates. The individu-
als with one or two risk alleles had a higher BMI (25. ± 3.3
kg/m2, n = 205) than those without a risk allele (24.8 ± 3.4
kg/m2, n = 790; p = 0.04).
Genotype-beta cell function and insulin resistance
Because the insulin level might be influenced by a hyper-
glycemic agent, 493 non-diabetic control subjects with
fasting insulin concentrations available were studied.
Only at the FTO and CDKAL1 loci was a relationship
between SNP and phenotype observed. As shown in
Table 3: Meta-analysis for SNPs at nine genetic loci in the Chinese Han population living in China.
Chr SNP Gene Risk 
allele
Case risk AF Control risk AF P for 
heterogeneity
OR (95%CI) P for overall 
effect
References
9 rs10811661 CDKN2A/B T 0.60 0.54 0.07 1.28(1.21-1.36) <0.00001 [10-12]
8 rs13266634 SLC30A8 C 0.58 0.52 0.10 1.19(1.13-1.25) <0.00001 [6,10-12,27]
6 rs10946398 CDKAL1 C 0.45 0.41 0.03 1.24(1.13-1.37) <0.00001 [10,12,15]
11 rs 2237892 KCNQ1 C 0.72 0.66 0.01 1.33(1.18-1.49) <0.00001 [23-26]
4 rs6446482 WFS1 G 0.96 0.95 0.53 1.26(1.06-1.51) 0.009 [12]
10 rs5015480 HHEX C 0.20 0.16 0.12 1.24(1.12-1.38) <0.00001 [10,11]
17 rs7501939 TCF2 T 0.28 0.26 0.88 1.16(1.08-1.24) <0.00001 [5,38]
3 rs4402960 IGF2BP2 T 0.27 0.24 0.22 1.14(1.06-1.22) 0.0002 [10,11,15]
16 rs8050136 FTO A 0.14 0.12 0.80 1.17(1.09-1.27) <0.00001 [11,12,14,30]
AF: allele frequency; OR: Odds ratio; CI: confidence interval; All of the calculations for the meta-analysis were carried out on Revman4.2. Cochran's 
x2-based Q-statistic test was used to assess heterogeneity in all studies, and a random-effect model was adopted when heterogeneity existed, 
otherwise a fixed-effects model was appropriate. Combined ORs were calculated using the Mantel-Haenszel (fixed-effects) and DerSimonian and 
Laird (random-effects) tests. The significant P value of the overall ORs was determined using a Z-test.Han et al. BMC Medical Genetics 2010, 11:81
http://www.biomedcentral.com/1471-2350/11/81
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Table 4, the individuals with a risk allele of FTO-
rs8050136 had a higher HOMA-ί, HOMA-IR, BMI, and
fasting serum insulin level than those without the risk
allele(under a dominant model), and the effects of FTO
on HOMA-ί, HOMA-IR, and the fasting serum insulin
level were independent of gender, age, and BMI. In addi-
tion, CDKAL1-rs10946398 significantly affected beta cell
function independent of gender, age, and BMI, and the
individuals with 2 risk alleles had a lower HOMA-ί than
those without a risk allele (under the recessive model).
Discussion
In the present study, we have replicated the associations
between seven SNPs (CDKAL1-rs10946398,  IGF2BP2-
rs4402960,  SLC30A8-rs13266634,  CDKN2A/B-
rs10811661,  HHEX-rs5015480,  FTO-rs8050136, and
KCNQ1-rs2237892) with T2D in the Chinese Han popu-
lation living in China, and an association between WFS1-
rs6446482 with early-onset T2D was also identified in the
subgroup analysis. For the genotype-phenotype analysis
in control subjects, we found that the SNP at FTO loci
showed a significant association with BMI, beta cell func-
tion, and insulin sensitivity. Moreover, we observed the
influence of CDKAL1  on beta cell function, and our
meta-analysis also indicated the SNPs at TCF2-rs7501939
and WFS1-rs6446482 were associated with T2D.
SLC30A8, HHEX, CDKAL1, CDKN2A/B, IGF2BP2, and
FTO are among the first cohort of susceptibility genes
discovered in relatively small samples by GWAS with
ORs ranging from 1.14-1.20 [1-6]. In the present study,
the OR values for the risk alleles range from 1.19-1.27,
which are slightly higher than the Caucasian population
[1-6], and slightly different from other Chinese studies.
This is partly due to the features of our study (e.g., small
sample sizes, enriched subjects with earlier onset T2D,
and older subjects without a family history of T2D in the
control group) or the difference in the studied population
in genetic background as observed for the TCF7L2 and
KCNQ1 genes in previous reports [7,21,22]. Based on our
observation, we found that the minor allele frequencies of
FTO, WFS1, TCF2,  HHEX, and IGF2BP2  were much
lower, while those of CDKAL1, CDKN2A/B,  SLC30A8,
and  KCNQ1  were much higher than in the Caucasian
population (Additional file 1, Table S1), indicating the dif-
ferent genetic background between Caucasians and the
Chinese population. Our findings on CDKAL1, SLC30A8,
CDKN2A/B, and KCNQ1 are further supported by sev-
eral recent studies in the Chinese population [10-12,23-
27]. However, for IGF2BP2, no significant association was
demonstrated with T2D [10,11]. For HHEX, a relation-
ship between the SNPs at the HHEX locus and T2D was
reported among Chinese living in Shanghai, but not
among Chinese in Beijing, even in the same study [10].
We believe that the inconsistent results of these studies
are due, at least in part, to the small sample size [10] and
the different enrollment criteria. For example, the plasma
glucose at 2 hours during the OGTT was not determined
and some subjects with impaired glucose tolerance(IGT)
or T2D might have been falsely classified into the control
group [10], or some adolescents in the control group may
develop T2D in the future [11]. Therefore, the meta-anal-
ysis of the combined data from these published studies
Table 4: The genotype-phenotype relationship in control individuals at CDKAL1 and FTO genetic loci.
SNPs Genotype Male/
Female
Age (yrs) BMI (kg/m2) Fasting 
glucose 
(mmol/l)
Fasting insulin 
(pmol/l)
HOMA-ί HOMA-IR
CDKAL1 
rs10946398
AA 40/117 57 ± 8 25.1 ± 2.9 5.2 ± 0.4 50.1(34.1-71.7) 81.5(59.2-118.1) 1.6(1.2-2.5)
AC 65/188 57 ± 8 25.1 ± 3.2 5.3 ± 0.4 46.7(36.9-66.9) 80.5(57.3-109.8) 1.5(1.1-2.3)
CC 22/56 57 ± 9 25.9 ± 3.6 5.4 ± 0.4 48.1(36.9-64.8) 77.1(57.4-106.3) 1.6(1.2-2.3)
Dominant 
p-value
- - 0.650 0.140 0.268 0.142 0.268
Additive p-
value
- - 0.131 0.161 0.525 0.034(0.019)a 0.155
Recessive 
p-value
- - 0.053 0.044(0.046)a 0.802 0.043(0.021)a 0.228
FTO 
rs8050136
CC 108/278 57 ± 8 25.1 ± 3.2 5.3 ± 0.4 45.3(32.7-63.4) 76.6(54.3-106.3) 1.5(1.1-2.2)
CA/AA 19/85 57 ± 8 25.8 ± 3.2 5.2 ± 0.4 55.7(43.2-75.2) 94.3(73.5-129.6) 1.8(1.4-2.6)
Dominant 
p value
-- 0.04(0.037)b 0.148 <0.00001(0.005)a 0.004(0.017)a 0.005(0.035)a
Data are the means ± SD, or median(interquartile range). Test models refer to the minor allele. Only the dominant model was considered in which 
the minor allele homozygote count was ≤10. Bold: P-value < 0.05. Unadjusted p values without parentheses and p values with parentheses 
adjusted for a (gender, age, and BMI) and b (gender and age).Han et al. BMC Medical Genetics 2010, 11:81
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and our study is necessary for evaluating the association
of these genetic loci with T2D and the effect of size in the
Chinese population.
The studies in other ethnic groups have made clear that
the association between FTO  and T2D is mediated
through its effect on body weight [2,3,28,29]. In the pres-
ent study, we have confirmed the association between
FTO and BMI and T2D, and the association with T2D
remained of borderline significance (p = 0.046), even after
adjustment for BMI. The independent effect of FTO on
T2D is consistent with a recent study [14]. It is worth
noticing that the study results on FTO in a Chinese popu-
lation have been conflicting. The study in Chinese living
in Taiwan has reported this association with BMI, but not
T2D [30]. However, another study in a Chinese popula-
tion living in Shanghai did not show an association
between FTO-rs8050136 and BMI or T2D [13]. The dis-
crepancy is partly due to population-specific bias, insuffi-
cient power, and the effects of duration and treatment for
T2D, which may have distorted the real relationships
among BMI, genotypes, and T2D. Europeans and Asians
are different in their environmental risk profiles, body
composition, and genetic background. In particular,
As i a n s  a r e  a t  r i s k  f o r  T 2 D  a t  a  l o w e r  l ev e l  o f  o be s i t y ,
partly due to their increased predisposition to visceral
adiposity [31] and reduced pancreatic β-cell function
[32]. Our pooled analysis demonstrated FTO really con-
tributed to T2D in Chinese. Unfortunately, the individual
BMI from all published studies are not available for meta-
analysis and so it is difficult to determine whether or not
the association is really independent of BMI. As observed
in the present study, FTO-rs8050136 may directly or indi-
rectly affect HOMA-ί and HOMA-IR, and a reasonable
interpretation is that the control subjects who carry the
risk allele of FTO are prone to insulin resistance, and are
able to increase insulin secretion to completely compen-
sate for low insulin sensitivity to keep glucose homeosta-
sis. Thus, it is necessary to clarify the pathogenesis of the
contribution of FTO to T2D.
I t  h as  bee n  s h o wn  t h a t  c o m m o n  S NP s  a t  t h e  W F S 1
locus are clearly associated with T2D in a Caucasian pop-
ulation [8,33], but not in a Chinese population in a recent
study with insufficient power [12]. However, we observed
an association between WFS1-rs6446482 with T2D in
our meta-analysis, and early-onset T2D in our own sam-
ple. Wolfram syndrome, characterized by early-onset dia-
betes, optic atrophy, deafness, and diabetes insipidus is
due to mutations of the WFS1 gene [34], which regulates ί
cell function in mice [35] and glucagon-like peptide 1-
induced insulin secretion in humans [36], suggesting that
impaired beta cell function in subjects with the risk allele
of WFS1 may promote the onset of T2D as seen in other
monogenetic diabetes [37,38]. Thus, it is necessary to
replicate this study in a larger sample and sequence this
gene for real causative variants.
The C allele of rs7501939 and the A allele of rs4430796
in the TCF2 gene were shown by GWAS to confer risk for
prostate cancer and are protective for T2D [5]. However,
that study did not show a significant association between
TCF2-rs7501939 with T2D in a Chinese sample [5], con-
sistent with the results of our study. The negative finding
s h o u l d  b e  a t t r i b u t e d  t o  t h e  i n s u f f i c i e n t  p o w e r  o f  t h i s
study (Additional file 1, Table S1). Nevertheless, in
another Chinese study involving TCF2-rs4430796 [38],
the association was replicated. A meta-analysis of com-
bin ed da ta  fr om  bo t h t he  p r evi ous  s t udy [ 38 ]  a nd ou r
study in Chinese confirmed the findings.
There are now as many as 17 genetic loci associated
with T2D. In our previous Chinese Han studies
[22,39,40], we have assessed the effects of PPARG,
KCNJ11, and TCF7L2, and successfully replicated the
associations between the KCNJ11 and TCF7L2 loci with
T2D. However, the remaining six genetic loci were identi-
fied by meta-analysis of GWAS, including JAZF1,
TSPAN8-LGR5, THADA, ADAMTS9, NOTCH2-
ADAM30, and MTNR1B, of which only MTNR1B in one
study was shown to increase the risk for T2D and an
increased fasting plasma glucose concentration in the
Chinese Han [12,41]. Therefore, further investigation
with a large sample and meta-analysis is needed to con-
firm the roles in the Chinese Han population.
Conclusions
In summary, the present study has confirmed an associa-
tion between genetic variations at CDKAL1, IGF2BP2,
SLC30A8, CDKN2A/B, HHEX, KCNQ1, and FTO  loci
with T2D in the Chinese Han population living in China.
Our meta-analysis has provided the evidence that the
variants at TCF2 and WFS1 genetic loci also contribute to
the genetic susceptibility for T2D in Chinese.
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